Shui Qiu

711 total citations
21 papers, 526 citations indexed

About

Shui Qiu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Shui Qiu has authored 21 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Surgery. Recurrent topics in Shui Qiu's work include Bone health and treatments (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Bone Metabolism and Diseases (3 papers). Shui Qiu is often cited by papers focused on Bone health and treatments (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Bone Metabolism and Diseases (3 papers). Shui Qiu collaborates with scholars based in China and Germany. Shui Qiu's co-authors include Lin Tao, Yue Zhu, Nannan Shao, Yongfeng Jin, Keda Yang, Zhengbo Tao, Xiaotong Meng, Lin Shen, Kaicheng Wen and Rui Zhao and has published in prestigious journals such as Life Sciences, Medicine and Osteoporosis International.

In The Last Decade

Shui Qiu

21 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shui Qiu China 14 316 169 61 53 46 21 526
Lina Huang China 11 240 0.8× 172 1.0× 31 0.5× 22 0.4× 35 0.8× 15 435
Ying Yao China 14 462 1.5× 219 1.3× 53 0.9× 54 1.0× 123 2.7× 37 738
Stefan Rudloff Germany 11 504 1.6× 74 0.4× 102 1.7× 79 1.5× 38 0.8× 22 805
Sukanya Suresh United States 11 185 0.6× 76 0.4× 66 1.1× 29 0.5× 35 0.8× 21 509
Xiang Lin China 13 249 0.8× 73 0.4× 102 1.7× 41 0.8× 153 3.3× 27 686
Holger Summer Germany 10 324 1.0× 160 0.9× 44 0.7× 47 0.9× 35 0.8× 14 660
Gumpei Yoshimatsu Japan 18 249 0.8× 68 0.4× 182 3.0× 49 0.9× 58 1.3× 73 873
Qilan Ning China 17 379 1.2× 334 2.0× 58 1.0× 26 0.5× 73 1.6× 31 688
Jiabi Zhang China 8 193 0.6× 136 0.8× 37 0.6× 49 0.9× 101 2.2× 12 490
Junteng Zhou China 12 268 0.8× 57 0.3× 50 0.8× 31 0.6× 46 1.0× 24 471

Countries citing papers authored by Shui Qiu

Since Specialization
Citations

This map shows the geographic impact of Shui Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shui Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shui Qiu more than expected).

Fields of papers citing papers by Shui Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shui Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shui Qiu. The network helps show where Shui Qiu may publish in the future.

Co-authorship network of co-authors of Shui Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Shui Qiu. A scholar is included among the top collaborators of Shui Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shui Qiu. Shui Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Shui, et al.. (2024). Enhanced osteogenic differentiation in 3D hydrogel scaffold via macrophage mitochondrial transfer. Journal of Nanobiotechnology. 22(1). 540–540. 8 indexed citations
2.
Yang, Keda, et al.. (2023). Metformin reverses oxidative stress‑induced mitochondrial dysfunction in pre‑osteoblasts via the EGFR/GSK‑3β/calcium pathway. International Journal of Molecular Medicine. 51(4). 13 indexed citations
3.
Yang, Keda, et al.. (2022). The role of melatonin in the development of postmenopausal osteoporosis. Frontiers in Pharmacology. 13. 975181–975181. 16 indexed citations
4.
Yang, Keda, et al.. (2022). Metformin Promotes Differentiation and Attenuates H2O2-Induced Oxidative Damage of Osteoblasts via the PI3K/AKT/Nrf2/HO-1 Pathway. Frontiers in Pharmacology. 13. 829830–829830. 26 indexed citations
5.
Qiu, Shui, et al.. (2022). Osteoporosis in Patients With Respiratory Diseases. Frontiers in Physiology. 13. 939253–939253. 13 indexed citations
6.
Tao, Zhengbo, Jinpeng Wang, Kaicheng Wen, et al.. (2021). Pyroptosis in Osteoblasts: A Novel Hypothesis Underlying the Pathogenesis of Osteoporosis. Frontiers in Endocrinology. 11. 548812–548812. 53 indexed citations
7.
Gong, Zimu, Wacili Da, Yihao Tian, et al.. (2021). Exogenous melatonin prevents type 1 diabetes mellitus–induced bone loss, probably by inhibiting senescence. Osteoporosis International. 33(2). 453–466. 12 indexed citations
8.
Qiu, Shui, et al.. (2020). Melatonin induces mitochondrial apoptosis in osteoblasts by regulating the STIM1/cytosolic calcium elevation/ERK pathway. Life Sciences. 248. 117455–117455. 20 indexed citations
9.
Zhao, Rui, Lin Tao, Shui Qiu, et al.. (2020). Melatonin rescues glucocorticoid-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways. Life Sciences. 257. 118044–118044. 42 indexed citations
10.
Ma, Yue, et al.. (2020). Metformin promotes cell proliferation and osteogenesis under high glucose condition by regulating the ROS‑AKT‑mTOR axis. Molecular Medicine Reports. 22(4). 3387–3395. 22 indexed citations
11.
Ma, Yue, et al.. (2020). Melatonin Inhibits Glucose-Induced Apoptosis in Osteoblastic Cell Line Through PERK-eIF2α-ATF4 Pathway. Frontiers in Pharmacology. 11. 40 indexed citations
12.
Qiu, Shui, Lin Tao, & Yue Zhu. (2019). Marital Status and Survival in Osteosarcoma Patients: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database. Medical Science Monitor. 25. 8190–8203. 24 indexed citations
13.
Zügel, Martina, et al.. (2018). Moderate intensity continuous training reverses the detrimental effects of ovariectomy on RyR1 phosphorylation in rat skeletal muscle. Molecular and Cellular Endocrinology. 481. 1–7. 3 indexed citations
14.
Meng, Xiaotong, et al.. (2018). Overexpression of septin-7 inhibits melatonin-induced cell apoptosis in human fetal osteoblastic cells via suppression of endoplasmic reticulum stress. Molecular Medicine Reports. 17(1). 4817–4822. 8 indexed citations
15.
Meng, Xiaotong, et al.. (2018). MicroRNA-125b-1-3p mediates intervertebral disc degeneration in rats by targeting teashirt zinc finger homeobox 3. Experimental and Therapeutic Medicine. 15(1). 13–13. 9 indexed citations
16.
Meng, Xiaotong, et al.. (2018). miR-590-3p mediates melatonin-induced cell apoptosis by targeting septin 7 in the human osteoblast cell line hFOB 1.19. Molecular Medicine Reports. 17(5). 7202–7208. 17 indexed citations
17.
Qiu, Shui, Lili Cao, Yue Qiu, et al.. (2017). Malignant phosphaturic mesenchymal tumor with pulmonary metastasis. Medicine. 96(17). e6750–e6750. 28 indexed citations
18.
Jin, Yongfeng, et al.. (2017). LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.. PubMed. 21(14). 3176–3184. 152 indexed citations
19.
Qiu, Shui. (2010). Protective Effect of Mangiferin on Kidney in Diabetic Rats. 1 indexed citations
20.
Qiu, Shui, et al.. (2000). [A preliminary study on the activation of superoxide dismutase by Tiopronin in patients with chronic hepatitis B].. PubMed. 14(4). 355–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026